ALNOV Novacyt S.A.

0.4842USD0.4415 EUR · EPA+1.49%Mkt Cap: 34.97M USDP/E: —

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…

Institutional holders3 on file

Key Statistics

Company
Market Cap34.97M USD
Enterprise Value36.07M USD
Revenue (TTM)28.70M USD
Gross Profit16.61M USD
Net Income (TTM)-30.13M USD
Revenue/Share0.40 USD
Last Price0.4842 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees228
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0010397232
Valuation
P/E (Trailing)—
P/E (Forward)1.69
PEG—
EV/EBITDA10.42
EV/Revenue1.26
P/S1.46
P/B1.41
EPS (TTM)-0.47 USD
EPS (Forward)0.34 USD
52W Range
0.318120% of range1.141
52W High1.141 USD
52W Low0.3181 USD
Profitability
Gross Margin62.98%
Oper. Margin-50.31%
EBITDA Margin14.48%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
ROIC-72.40%
ROCE-35.89%
Growth
Revenue Growth18.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.86M USD
CapEx (TTM)1.16M USD
FCF Margin26.45%
FCF Yield21.70%
Net Debt1.74M USD
Net Debt/EBITDA0.42
Net Debt/FCF0.23
Balance Sheet
Debt/Equity0.45
Current Ratio3.14
Quick Ratio2.19
Book Value/Sh0.41 USD
Cash/Share0.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.72.47M
Float71.57M
Insiders0.06%
Institutions0.00%
Technical
SMA 500.5106 (-5.2%)
SMA 2000.4914 (-1.5%)
Beta1.36
S&P 52W Chg12.00%
Avg Vol (30d)126.89K
Avg Vol (10d)198.47K
Technical Indicators
RSI (14)48.3
MACD-0.0067
MACD Signal-0.0098
MACD Hist.+0.0031
BB Upper0.5113 USD
BB Middle0.4791 USD
BB Lower0.4469 USD
BB Width13.46%
ATR (14)0.0196 USD
Vol Ratio (20d)0.54x

About Novacyt (EPA: ALNOV)

›

Novacyt (EPA: ALNOV) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 228 employees.

The shares were at 0.4415 EUR on 19 November 2026, up 2.7% over 52 weeks. Its 52-week range is 0.2900 EUR to 1.040 EUR: the price is 57.5% below the high and 52.2% above the low.

Its market capitalisation is 31.89M EUR.

Novacyt reports return on equity of -97.9%, an operating margin of -50.3% and revenue up 18.0% year over year.

Its debt exceeds its cash by 1.32M GBP, a debt-to-equity ratio of 0.45. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.